US Broker Ratings

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Unpacking a 324.93% Upside Potential

A2Z Cust2Mate Solutions Corp. (AZ) stands out in the technology sector with its innovative approach to retail automation and smart cart solutions, promising a substantial potential upside of 324.93%. With..

Sprinklr, Inc. (CXM) Stock Analysis: A 57.66% Potential Upside Awaits Investors

Sprinklr, Inc. (NYSE: CXM) is capturing investor attention with its significant potential upside of 57.66%. Operating within the competitive technology sector, Sprinklr specializes in application software, offering a broad suite..

Sanara MedTech Inc. (SMTI) Investor Outlook: Strong Buy Ratings Suggest 75% Upside Potential

Sanara MedTech Inc. (NASDAQ: SMTI), a burgeoning player in the healthcare sector, is capturing investor attention with its promising growth potential and innovative product portfolio. Specializing in medical instruments and..

Aura Biosciences, Inc. (AURA) Stock Analysis: Unveiling a Potential 254% Upside

Aura Biosciences, Inc. (NASDAQ: AURA), a trailblazer in the biotechnology sector, is capturing the attention of individual investors with its ambitious pipeline and promising growth potential. As a clinical-stage company..

Fastly, Inc. (FSLY) Stock Analysis: Navigating a 22.52% Potential Upside in the Tech Sector

Fastly, Inc. (NYSE: FSLY), a key player in the Technology sector, is capturing investor attention with its 22.52% potential upside. Known for its edge cloud platform services, Fastly is revolutionizing..

NICE Ltd (NICE) Investor Outlook: Exploring a 42% Potential Upside in AI-Powered Tech

NICE Ltd (NICE), a leader in AI-powered cloud platforms based in Israel, is making waves in the technology sector, specifically within the software application industry. With a current market capitalization..

TruBridge, Inc. (TBRG) Stock Analysis: Navigating Healthcare Tech with a 12.43% Potential Upside

TruBridge, Inc. (NASDAQ: TBRG) is a notable player in the healthcare sector, specifically within the health information services industry. Headquartered in Mobile, Alabama, TruBridge has carved a niche in providing..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 53.59% Potential Upside with Strategic Partnerships

CytomX Therapeutics, Inc. (CTMX), a pioneering force in the biotechnology sector, is making waves in the oncology-focused biopharmaceutical landscape. With a market capitalization of approximately $896.31 million, the company is..

Lyft, Inc. (LYFT) Investor Outlook: Assessing a 30.95% Potential Upside Amid Sector Challenges

Lyft, Inc. (LYFT), a prominent player in the technology sector, operates within the software application industry, providing a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. While..

SANUWAVE Health, Inc. (SNWV)

⚠️ No article content returned.

..

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector

Nyxoah SA (NASDAQ: NYXH), a Belgium-based innovator in the medical technology space, is garnering interest from investors due to its robust growth potential and strategic focus within the healthcare sector...

Shopify Inc. (SHOP) Stock Analysis: A 29.56% Potential Upside and Key Analyst Ratings

Shopify Inc. (SHOP) is capturing the spotlight in the world of technology stocks, thanks to its robust market presence and significant growth potential. Trading on the New York Stock Exchange,..

Phathom Pharmaceuticals (PHAT): Investor Outlook on a Biotech with 68% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a burgeoning entity in the biotechnology sector, focusing on innovative treatments for gastrointestinal diseases. With a market capitalization of $1.06 billion, the company has..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 73.56% Potential Upside Awaits Investors

For investors with a keen eye on growth opportunities in the healthcare sector, Viemed Healthcare, Inc. (VMD) presents an intriguing proposition. With an enticing potential upside of 73.56%, as indicated..

UroGen Pharma Ltd. (URGN) Stock Analysis: Investors Eye 83% Upside Amid Biotech Innovations

UroGen Pharma Ltd. (NASDAQ: URGN) is making waves in the biotechnology sector, standing out with its promising innovations in urothelial and specialty cancers. With the current stock price at $19.23,..

XOMA Royalty Corporation (XOMA): Investor Outlook Reveals a Compelling 136% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing prospect for investors with a focus on the biotechnology sector. As a dedicated royalty aggregator, XOMA has carved out a unique niche..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling serious diseases. Operating out of San Diego, California, this..

Varex Imaging Corporation (VREX) Investor Outlook: 21.55% Potential Upside and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, Varex Imaging Corporation (NASDAQ: VREX) presents an intriguing proposition. With a market capitalization of $593.16 million, Varex operates in the medical devices..

Sprout Social, Inc (SPT) Stock Analysis: A Look at Its 64% Potential Upside in a Competitive Market

Sprout Social, Inc. (NYSE: SPT), with its current stock price at $9.51, presents an intriguing opportunity for investors, particularly given its potential upside of 64.04% based on the average target..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Biotech Stock Poised for 246.72% Upside with Promising PAH Treatment

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to treating pulmonary arterial hypertension (PAH). As a key..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds